Conference on Health Economics and Outcomes Research 2009 (UK2009)

Venue: BSG House

Location: London, United States

Event Date/Time: Jun 04, 2009 End Date/Time: Jun 05, 2009
Report as Spam


"Linking the care that people get to the outcomes they experience is key"

Pharmacoeconomics is an area that is increasing importance every year. Capped health budgets and rising drug costs have led to the high level of interest in the use of economic analysis for decisions about the purchase and subsidisation of new pharmaceutical products. The key point is to establish the relationship between any improved health outcomes with new drugs (compared with established treatments) to the net costs associated with their use.

Health economics is crucial in a world with an ageing population and an ever higher strain on health budgets. Pharmaceutical and biotech companies must be able to measure and prove the value of their products in more sophisticated ways and they must account for many different things. In recent years the burden of proof has fallen squarely on the shoulders of industry and this is unlikely to change. Therefore advancements in pharmacoeconomics and greater understanding of health outcomes and the broader context of health economics is essential.

 Health Economics and Outcomes Research 2009 provides the ideal forum for industry decision-makers, pharmacoeconomic analysts and academics alike to keep up with the latest developments in thinking and practice.

By attending this conference you will:
• Apply the latest methodological approaches and tools to optimise your pharmacoeconomic analyses
• Move beyond methodology and apply insights from related disciplines that can breathe new life into your analyses
• Implement insights from developing pharmacoeconomic models in complicated and rapidly-evolving therapeutic areas defined by their complexity
• Address the broader societal context and take insights from case studies of success and failure
• Tackle common problems facing all pharmacoeconomics, communicate better with payers and develop analyse that provide win-win solutions

Target Audience:
• Branded Biotechnology Companies
• Pharmaceutical Companies
• Branded Generics Firms
• Health Economics/Outcomes Service Providers
• Regulatory Bodies
• Academic Organisations

Who will be there:
VP’s, Directors, Heads and Managers of:
• Health Economics
• Outcomes Research
• Pharmacoeconomics
• Market Access
• Local and international economic strategy
• Pricing & Reimbursement
• Strategy Analysis
• Medical Affairs
• Medical Information
• Evidence Based Medicine
• Epidemiology Project Management
• Regulatory Affairs and Compliance
• Clinical Pharmacology
• Sales & Marketing

Academic departments and service providers focused on:
• Health Economics
• Outcomes Research
• Pharmacoeconomics
• Regulatory Affairs
• Evidence based medicine


BSG House
BSG House, London, UK
United States